CECCHETTI, Violetta
 Distribuzione geografica
Continente #
NA - Nord America 6.775
EU - Europa 5.266
AS - Asia 4.729
SA - Sud America 613
AF - Africa 80
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 10
Totale 17.485
Nazione #
US - Stati Uniti d'America 6.664
SG - Singapore 1.965
IT - Italia 1.008
UA - Ucraina 892
IE - Irlanda 869
CN - Cina 785
VN - Vietnam 692
HK - Hong Kong 686
SE - Svezia 659
RU - Federazione Russa 547
BR - Brasile 528
DE - Germania 351
FI - Finlandia 263
KR - Corea 196
GB - Regno Unito 171
BE - Belgio 112
TR - Turchia 78
JP - Giappone 73
FR - Francia 69
PL - Polonia 69
IN - India 56
CA - Canada 52
MX - Messico 45
RO - Romania 44
NL - Olanda 41
CH - Svizzera 37
AR - Argentina 35
BD - Bangladesh 33
UZ - Uzbekistan 31
ZA - Sudafrica 30
ES - Italia 29
AT - Austria 27
CZ - Repubblica Ceca 26
ID - Indonesia 18
IQ - Iraq 18
PK - Pakistan 15
EC - Ecuador 14
CI - Costa d'Avorio 11
LB - Libano 11
AU - Australia 10
EG - Egitto 10
LT - Lituania 10
MA - Marocco 10
CL - Cile 8
AE - Emirati Arabi Uniti 7
DK - Danimarca 7
EU - Europa 7
GR - Grecia 7
IL - Israele 7
IR - Iran 7
KE - Kenya 7
SA - Arabia Saudita 7
BG - Bulgaria 6
UY - Uruguay 6
CO - Colombia 5
MY - Malesia 5
KZ - Kazakistan 4
OM - Oman 4
PA - Panama 4
PE - Perù 4
PY - Paraguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
BO - Bolivia 3
DZ - Algeria 3
HN - Honduras 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LV - Lettonia 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AM - Armenia 2
EE - Estonia 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
TM - Turkmenistan 2
TN - Tunisia 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CM - Camerun 1
CR - Costa Rica 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GF - Guiana Francese 1
GY - Guiana 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
Totale 17.474
Città #
Singapore 1.354
Chandler 1.091
Dublin 869
Hong Kong 673
Dong Ket 487
Jacksonville 480
Perugia 463
San Mateo 460
Ashburn 382
Boardman 307
Santa Clara 257
Medford 205
Princeton 203
Seoul 193
Beijing 183
Ann Arbor 167
Wilmington 159
Altamura 146
Andover 128
Lawrence 123
Moscow 118
Los Angeles 117
Brussels 112
Munich 99
New York 92
Ho Chi Minh City 87
Piscataway 76
Fremont 75
Tokyo 66
Des Moines 65
The Dalles 62
Saint Petersburg 57
Turku 54
São Paulo 49
West Jordan 48
Warsaw 46
Izmir 44
Nanjing 43
Redmond 43
Hanoi 39
Norwalk 39
Brooklyn 36
Dearborn 36
Woodbridge 35
Dallas 34
Denver 31
Atlanta 30
Orem 29
Helsinki 28
Rome 28
Falls Church 27
Bucharest 25
Chicago 25
Spoleto 25
Columbus 24
Hefei 24
Poplar 24
San Giustino 23
Montreal 22
San Paolo di Civitate 22
Houston 21
Redwood City 21
Stockholm 21
Shanghai 19
Chennai 18
London 18
Seattle 18
Phoenix 17
San Diego 17
San Francisco 17
Ankara 16
Den Haag 16
Johannesburg 16
San Jose 16
Philadelphia 15
Rio de Janeiro 15
Auburn Hills 14
Boston 14
Charlotte 14
Chongqing 14
Secaucus 14
Hanover 13
Manchester 13
Mexico City 13
Olomouc 13
Council Bluffs 12
Curitiba 12
Guangzhou 12
Abidjan 11
Bologna 11
Da Nang 11
Dhaka 11
Porto Alegre 11
Tashkent 11
Timisoara 11
Brasília 10
Recife 10
Amsterdam 9
Belo Horizonte 9
Lappeenranta 9
Totale 10.852
Nome #
1,4-Benzothiazine-2-carboxylic Acids 1-Oxide as Analogue of Antibacterial Quinolones 310
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 302
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 291
(1,4-Benzothiazinyloxy)alkylpiperazine Derivatives as Potential Antihypertensive Agents 289
6-Aminoquinolones, their Synthesis and their Use as Antibacterial Agents. 232
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 173
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 155
Sintesi di nuovi inibitori della pompa di efflusso NorA dello S. aureus: dalle 3-fenil-1,4-benzotiazine alle 2-fenilchinossaline 154
4H-1,4-Benzothiopyran-4-one-3-carboxylic Acids and 3,4-Dihydro-2H-isothiazolo[5,4-b][1]benzothiopyran-3,4-diones as Quinolone Antibacterial Analogs 147
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 139
Derivati benzotiazinici come inibitori della pompa estrudente MDR NorA dello Staphylococcus aureus 138
Attivatori dei canali KATP a struttura 1,4-benzotiazinica. Modificazioni in N-4 130
Attivatori dei canali K-ATP a struttura 1,4-benzotiazinica: modificazioni in C-2 e C-6 126
SINTESI DI NUOVI INIBITORI DELLA POMPA DI EFFLUSSO NorA DELLO S. aureus: DALLE 3-FENIL-1,4-BENZOTIAZINE ALLE 2-FENILCHINOLINE 125
6-Aminoquinolones: a New Class of Quinolone Antibacterials? 125
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 123
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 120
Chemometric Methodologies in a Quantitative Structure-Activity Relationship Study: the Antibacterial Activity of 6-Aminoquinolones 118
Chemometric Rationalization of the Structural and Physicochemical Basis for Selective Cyclooxygenase-2 Inhibition: Toward More Specific Ligands 116
New Insights on KCa3.1 Channel Modulation 114
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 113
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 113
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 112
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 111
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 111
Allosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development 110
6-Aminoquinolones as New Potential Anti-HIV Agents 109
Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-ethyl- and 6-Amino-8-methoxyquinolones 109
A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors 109
Process for the Preparation of 9-Fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic Acid Hydrochloride 108
8-Methyl-7-substituted-1,6-naphthyridine-3-carboxylic Acids as New 6-Desfluoroquinolone Antibacterials 108
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 108
Syhtesis and Biological Evaluation of 2-Phenylquinolones Targeted at Tat/TAR Recognition 106
6-Desfluoroquinolones as promising HIV transcription inhibitors 106
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 106
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 106
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 106
Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View 106
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 105
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 103
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 103
7-(Disubstituted thiazolyl)-3,5-dihydroxy-6-heptenoic/heptanoic acid derivatives as HMG-COa reductase inhibitors 101
A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates 101
Cell-dependent Interference with viral transactivation by 6-aminoquinolone derivatives. 100
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 100
A Comprehensive Structural Overview of p38 Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site Binders 100
A New Derivative with Ultra-Potent Anti-HIV Activity 99
Bicyclic octahydrocyclohepta[b]pyrrol-4(1H)one derivatives as novel selective anti-hepatitis C virus agents 99
Advantageous Use of Ionic Liquids for the Synthesis of Pharmaceutically Relevant Quinolones 99
Disegno e Sintesi di Nuovi Inibitori Allosterici della NS5B Polimerasi dell'HCV 98
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 98
A new 6-aminoquinolone compound with anti-HCMV activity 97
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 97
6-Aminoquinolones: photostability, cellular distribution and phototoxicity. 96
Chemometric rationalization of the structural features affecting the antibacterial activity of quinolones 96
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 96
Synthesis and Antibacterial Evaluation of [1,3]Benzothiazino[3,2-a]quinoline and [3,1]Benzothiazino[1,2-a]quinoline-6-carboxylic Acid Derivatives 95
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 95
Deciphering the molecular recognition mechanism of multidrug resistance staphylococcus aureus nora efflux pump using a supervised molecular dynamics approach 95
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 95
Enantiomers of 8-(3-tert-Butylamino-2-hydroxypropoxy)-3,4-dihydro-3-oxo-2H-(1,4)benzothiazine: Racemic Resolution, Chiral Synthesis and Biological Activity. 95
The antibacterial activity of quinolones against E.coli: a chemometric study 93
Chemometric Rationalization of the Structural Features Affecting the Antibacterial Activity of Quinolones Against Staphylococcus aureus 92
QSAR study and VolSurf characterization of anti-HIV quinolone library 92
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 92
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 92
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 92
N-Benzoyl-N-methylsulfonyl anthranilates: unexpected cyclization reaction to 4-alkoxy-2,1-benzothiazines 91
S. aureus NorA efflux pump: the discovery of new potent inhibitors 91
New Heterocyclic Ring Systems. XIII.7,11-Dithiaazasteroid Analogues 90
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 90
Synthesis of Novel Inhibitors of the S. aureus Efflux pumps: from the 4-hydroxy-2-phenylquinolines to the 4-hydroxy-2-phenylquinazolines 90
p38 alpha MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening 90
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 90
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. 89
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 89
Synthesis of 2-(Arylamino)ethanethiols via Lewis Acid catalyzed Aminolysis of 2,2-Dimethylthiirane as Precursors of the 1,4-Benzothiazine Nucleus 88
Co-crystal structure determination and cellular evaluation of 1,4-dihydropyrazolo[4,3-c] [1,2] benzothiazine 5,5-dioxide p38α MAPK inhibitors 88
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 88
Highly Potent 1,4-Benzothiazine Derivatives as KATP-Channel Openers 87
RE-EVOLUTION OF THE 2-PHENYL-4-HYDROXYQUINOLINES: OPTIMIZATION OF A POTENT NEW CLASS OF S. AUREUS NorA EFFLUX PUMP INHIBITORS 87
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 87
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 87
Quinolones as potential anti HIV-1 agents targeted at Tat/TAR recognition 86
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 86
Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation 86
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 86
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 85
Pyrazolobenzothiazines as potent TNF-alpha production inhibitors. 85
In Vitro Activities of New Quinolones Against Helicobacter pylori 84
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 84
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 84
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 84
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 84
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein 83
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 83
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 83
One-Pot Synthesis of Rufloxacin 82
Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization 82
Studies of Anti-HIV Transcription Inhibitor Quinolones: Identification of Potent N1-Vinyl Derivatives 81
Totale 11.050
Categoria #
all - tutte 79.653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.653


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.346 0 0 0 0 0 152 209 14 233 68 147 523
2021/20222.004 58 337 42 129 145 17 48 570 88 58 241 271
2022/20233.237 227 527 49 304 282 338 3 164 1.156 24 119 44
2023/20241.396 83 192 68 32 24 39 292 34 171 93 169 199
2024/20253.419 51 287 122 298 403 167 289 194 591 199 545 273
2025/20263.728 497 452 341 884 923 631 0 0 0 0 0 0
Totale 18.075